☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
BioCryst Pharmaceuticals
PharmaShots Weekly Snapshots (November 06–10, 2023)
November 10, 2023
BioCryst Enters into a License Agreement with Clearside Biomedical for the Development of Avoralstat to Treat Diabetic Macular Ede...
November 6, 2023
Insights+: Key Deals of J.P. Morgan Healthcare Conference 2020
February 7, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
